Literature DB >> 7048099

Immunogenic fractions of Cryptococcus neoformans.

J R Graybill, D C Straus, T J Nealon, M Hague, R E Paque.   

Abstract

Cryptococcus neoformans cell and culture supernatant extracts were fractionated by ion exchange and gel filtration column chromatography. Various fractions were used to immunize mice, and to assess the release of migration inhibition factor, delayed type hypersensitivity, and protective immunity after challenge with C. neoformans. Results suggest that the C. neoformans fractions, which protect mice, contain a high molecular weight, predominantly carbohydrate antigen that can be distinguished from the capsular polysaccharide.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7048099     DOI: 10.1007/bf00436579

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  19 in total

1.  Assessment of cell-mediated immunity in the rat utilizing the agarose-droplet cell-migration-inhibition correlate of delayed-type hypersensitivity.

Authors:  T Nealon; S C Harris; R E Paque
Journal:  Biochem Biophys Res Commun       Date:  1978-04-14       Impact factor: 3.575

2.  Cell-mediated immunity in Cryptococcosis.

Authors:  J R Graybill; R H Alford
Journal:  Cell Immunol       Date:  1974-10       Impact factor: 4.868

3.  Experience with a new skin test antigen prepared from Cryptococcus neoformans.

Authors:  A J Atkinson; J E Bennett
Journal:  Am Rev Respir Dis       Date:  1968-04

4.  Passive immunization in murine cryptococcosis.

Authors:  J R Graybill; M Hague; D J Drutz
Journal:  Sabouraudia       Date:  1981-12

5.  Host defense in Cryptococcosis. III. In vivo alteration of immunity.

Authors:  J R Graybill; L Mitchell
Journal:  Mycopathologia       Date:  1979-12-28       Impact factor: 2.574

6.  Delayed-type hypersensitivity responses in infected mice elicited by cytoplasmic fractions of Cryptococcus neoformans.

Authors:  R J Hay; E Reiss
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

7.  Transfer of immunity to cryptococcosis by T-enriched splenic lymphocytes from Cryptococcus neoformans-sensitized mice.

Authors:  T S Lim; J W Murphy
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441

8.  Cryptococcal culture filtrate antigen for detection of delayed-type hypersensitivity in cryptococcosis.

Authors:  J W Murphy; N Pahlavan
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

9.  Host defense in cryptococcosis. III. Protection of nude mice by thymus transplantation.

Authors:  J R Graybill; L Mitchell; D J Drutz
Journal:  J Infect Dis       Date:  1979-10       Impact factor: 5.226

10.  Nonencapsulated Variant of Cryptococcus neoformans I. Virulence Studies and Characterization of Soluble Polysaccharide.

Authors:  T R Kozel; J Cazin
Journal:  Infect Immun       Date:  1971-02       Impact factor: 3.441

View more
  2 in total

1.  Extracellular proteins of Cryptococcus neoformans and host antibody response.

Authors:  L C Chen; L A Pirofski; A Casadevall
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

2.  Cellular immunity in a cutaneous model of cryptococcosis.

Authors:  J E Domer; F L Lyon; J W Murphy
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.